Board Meeting29 Jul 2026, 08:51 pm
Piramal Pharma Ltd Declares Unaudited Financial Results for Q1 FY27
AI Summary
Piramal Pharma Limited announced the outcome of its Board Meeting held on July 29, 2026. The Board approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026. The results, along with the Limited Review Reports by the Statutory Auditors, will be published in newspapers and are available on the company's website. The meeting commenced at 5:30 pm and concluded at 8:30 pm.
Key Highlights
- Board Meeting held on July 29, 2026.
- Unaudited Financial Results for Q1 FY27 approved.
- Standalone and Consolidated results declared.
- Limited Review Reports by Statutory Auditors enclosed.
- Results to be published in newspapers and on company website.
Price Impact
More from PPLPHARMA
More in Board Meeting